B1KZ46 AF NFT

6,7-dimethyl-8-ribityllumazine synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiaeek3qdbq4llbd3ijxsl2hfre4pfcez4qui7ppjehfnz5mapwoem/metadata.json
IPFS of structure file: 
bafybeic5jqedpyjobd6dtxbjabczpzdznd6r65xcqhhk5spobuxp3khkbe/AF-B1KZ46-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7a1388B6Aad67B04634A32f63b8A6D6005eab86c
First NFT owner address (bech32): 
genesis10gfc3d426easgc62xtmrhzndvqz74wrv0qh3l8
Current NFT ID #346441 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
346441
Accession (UniProt):
B1KZ46
Name::
6,7-dimethyl-8-ribityllumazine synthase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN LOCH MAREE / TYPE A3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B1KZ46 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B1KZ46|RISB_CLOBM 6,7-dimethyl-8-ribityllumazine synthase OS=Clostridium botulinum (strain Loch Maree / Type A3) OX=498214 GN=ribH PE=3 SV=1 MKIYEGRLTAEGLKVGIIVSRFNEFITSKLLAGSIDCLKRHGAKEDNIEVCWVPGAFEIPVIAKKMASKGKYDAVICLGAVIRGATPHFDYVSSEVSKGVAHVSLDKEVPVIFGVLTTDTIEQAIERAGTKAGNKGYDAAMSAIEMSNLMKVLD